Sugi Predict

Sugi Predict / Compounds / SCHEMBL398655

SCHEMBL398655

SCHEMBL398655

O=S(=O)(O)OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.62
▸ TSHR P16473 2/20 0.62
▸ LMNA P02545 1/20 0.62
▸ TDP1 Q9NUW8 1/20 0.62
▸ TXNRD1 Q16881 6/20 0.53
▸ TXNRD3 Q86VQ6 6/20 0.53
▸ TXNRD2 Q9NNW7 6/20 0.53
▸ FYN P06241 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ HTR2C P28335 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ HDAC3 O15379 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ CA2 P00918 4/20 0.33
▸ CA1 P00915 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2305805 1.00 ALDH1A1 (0.62) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL1056613 1.00 ALDH1A1 (0.62) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL432885 1.00 ALDH1A1 (0.62) ALDH1A1TSHRLMNATDP1TXNRD1
Ammonia Solution, Strong SCHEMBL19100895 0.98 ALDH1A1 (0.61) ALDH1A1TSHRLMNATDP1TXNRD1
Ammonia Solution, Strong SCHEMBL19100890 0.98 ALDH1A1 (0.61) ALDH1A1TSHRLMNATDP1TXNRD1
Ammonia Solution, Strong SCHEMBL19100618 0.98 ALDH1A1 (0.61) ALDH1A1TSHRLMNATDP1TXNRD1
Trimethylammonium SCHEMBL19100739 0.94 ALDH1A1 (0.56) ALDH1A1TSHRLMNATDP1TXNRD1
Trimethylammonium SCHEMBL19100769 0.94 ALDH1A1 (0.56) ALDH1A1TSHRLMNATDP1TXNRD1
Trimethylammonium SCHEMBL19100741 0.94 ALDH1A1 (0.56) ALDH1A1TSHRLMNATDP1TXNRD1
SCHEMBL7623530 0.94 ALDH1A1 (0.50) ALDH1A1TSHRLMNATDP1TXNRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023187065-A1 COATED ARTICLE FOR CULTURING PRIMARY CELLS AND STEM CELLS AND METHOD FOR PREPARING THE SAME DENOVOMATRIX GMBH (DE) 2023-10-05 — — WO claimed
CN-112695071-B High-density lipoprotein 3 determination reagent, method and kit 浙江伊利康生物技术有限公司 2022-12-30 — — CN claimed
CN-112695071-A High-density lipoprotein 3 determination reagent, method and kit 浙江伊利康生物技术有限公司 2021-04-23 — — CN claimed
CN-111748605-A Rapid, low sample volume cholesterol and triglyceride determination 赛拉诺斯知识产权有限责任公司 2020-10-09 — — CN claimed
WO-2018197688-A1 NON-COVALENTLY ASSEMBLED CONDUCTIVE HYDROGEL Technische Universität Dresden (DE) 2018-11-01 — — WO claimed
EP-2751575-B1 BLOOD SAMPLE ASSAY METHOD AXIS SHIELD AS (NO) 2018-09-12 — — EP claimed
WO-2017103263-A1 MULTI-LAYERED WOUND CARE PRODUCT BSN MEDICAL GMBH (DE) 2017-06-22 — — WO claimed
CN-104076158-B A kind of test kit for measuring HDL-C 深圳市新产业生物医学工程股份有限公司 2016-08-17 — — CN claimed
EP-2929046-A1 RAPID, LOW-SAMPLE-VOLUME CHOLESTEROL AND TRIGLYCERIDE ASSAYS Theranos, Inc. (US) 2015-10-14 — — EP claimed
CN-104076158-A Kit for measuring high-density lipoprotein cholesterol SHENZHEN NEW IND BIOMEDICAL ENGINEERING CO LTD 2014-10-01 — — CN claimed
WO-2014093399-A1 RAPID, LOW-SAMPLE-VOLUME CHOLESTEROL AND TRIGLYCERIDE ASSAYS THERANOS, INC. (US) 2014-06-19 — — WO claimed
CN-101551399-A Method for quantifying high-density lipoprotein cholesterol and low-density lipoprotein cholesterol BEIJING STRONG BIOTECHNOLOGIES (CN) 2009-10-07 — — CN claimed
US-20060008914-A1 Test device for determining the concentration of LDL-cholesterol in a sample SCHEURINGER KIM 2006-01-12 — — US claimed
US-6830758-B2 Patch containing drug; flexible backing; pressure sensitive adhesive LECTEC CORPORATION 2004-12-14 — — US claimed
EP-0893453-B1 Chiral separation of pharmaceutical compounds with charged cyclodextrins using capillary electrophoresis BECKMAN COULTER INC (US) 2004-04-07 — — EP claimed
US-20030077316-A1 Psoriasis patch AXOGEN CORPORATION 2003-04-24 — — US claimed
US-20020192273-A1 Therapeutic patch useful for the treatment of hemorrhoids LEC TEC CORPORATION 2002-12-19 — — US claimed
WO-2025049920-A1 METHODS AND COMPOSITIONS FOR SAMPLE PROCESSING Biomeme, Inc. (US) 2025-03-06 — — WO disclosed
US-5100878-A Administering Sulfated Cyclodextrin AMERICAN MAIZE-PRODUCTS COMPANY (US) 1992-03-31 — — US disclosed
WO-1991016905-A1 BLOCKING THE EFFECT OF TERATOGENS ON A FETUS AMERICAN MAIZE-PRODUCTS COMPANY (US) 1991-11-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020192273-A1 Therapeutic patch useful for the treatment of hemorrhoids PTGIR, PLOD3, PTGIS ALDH1A1 1131/4885TSHR 4136/4885LMNA 1538/4885
US-20030077316-A1 Psoriasis patch PEF1, ITCH, DSG1 ALDH1A1 3726/4885TSHR 3816/4885LMNA 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.